Renal assist device and treatment of sepsis-induced acute kidney injury in intensive care units

Contributions to Nephrology

Volumn 156, Issue , 2007, Pages 419-427

  Issa, Naim ^a   Messer, Jennifer ^a   Paganini, Emil P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ANIMAL; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL TRIAL; DISEASE MODEL; DOG; HEMOFILTRATION; HUMAN; INSTRUMENTATION; INTENSIVE CARE; INTENSIVE CARE UNIT; METHODOLOGY; RENAL REPLACEMENT THERAPY; SEPSIS; SURVIVAL RATE; SWINE;

ANIMALS; CLINICAL TRIALS; CRITICAL CARE; DISEASE MODELS, ANIMAL; DOGS; HEMOFILTRATION; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; KIDNEY, ARTIFICIAL; RENAL REPLACEMENT THERAPY; SEPSIS; SURVIVAL RATE; SWINE;

EID: 34247554402     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000102133     Document Type: Article

References (27)

1. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117-123.
2. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P: Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant 1996;11:293-299.
3. Benedict CR, Rose JA: Arterial norepinephrine changes in patients with septic shock. Circ Shock 1992;38:165-172.
4. Cumming AD, Driedger AA, McDonald JW, Lindsay RM, Solez K, Linton AL: Vasoactive hormones in the renal response to systemic sepsis. Am J Kidney Dis 1988;11:23-32.
5. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004;351:159-169.
6. Wang W, Jittikanont S, Falk SA, Li P, Feng L, Gengaro PE, Poole BD, Bowler RP, Day BJ, Crapo JD, Schrier RW: Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure. Am J Physiol Renal Physiol 2003;284:F532-F537.
7. Schor N: Acute renal failure and the sepsis syndrome. Kidney Int 2002;61:764-776.
8. Schiffl H, Lang SM, Fischer R: Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002;346:305-310.
9. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26-30.
10. Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Muller JM, Baumann G, Kox WJ, Bellomo R, Neumayer HH: Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 2004;43:444-453.
11. Schrier RW, Wang W, Poole B, Mitra A: Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004;114:5-14.
12. Fujigaki Y, Goto T, Sakakima M, Fukasawa H, Miyaji T, Yamamoto T, Hishida A: Kinetics and characterization of initially regenerating proximal tubules in S3 segment in response to various degrees of acute tubular injury. Nephrol Dial Transplant 2006;21:41-50.
13. Maeshima A, Sakurai H, Nigam SK: Adult kidney tubular cell population showing phenotypic plasticity, tubulogenic capacity, and integration capability into developing kidney. J Am Soc Nephrol 2006;17:188-198.
14. Yamashita S, Maeshima A, Nojima Y: Involvement of renal progenitor tubular cells in epithelialto-mesenchymal transition in fibrotic rat kidneys. J Am Soc Nephrol 2005;16:2044-2051.
15. Bussolati B, Camussi G: Adult stem cells and renal repair. J Nephrol 2006;19:706-709.
16. Oliver JA, Maarouf O, Cheema FH, Martens TP, Al-Awqati Q: The renal papilla is a niche for adult kidney stem cells. J Clin Invest 2004;114:795-804.
17. Lin F, Moran A, Igarashi P: Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 2005;115:1756-1764.
18. Humes HD, Fissell WH, Weitzel WF, Buffington DA, Westover AJ, MacKay SM, Gutierrez JM: Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells. Am J Kidney Dis 2002;39:1078-1087.
19. Humes HD, Weitzel WF, Bartlett RH, Swaniker FC, Paganini EP, Luderer JR, Sobota J: Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 2004;66:1578-1588.
20. Smith PL, Buffington DA, Humes HD: Kidney epithelial cells. Methods Enzymol 2006;419:194-207.
21. Humes HD, MacKay SM, Funke AJ, Buffington DA: Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int 1999;55:2502-2514.
22. Nikolovski J, Gulari E, Humes HD: Design engineering of a bioartificial renal tubule cell therapy device. Cell Transplant 1999;8:351-364.
23. Fissell WH, Dyke DB, Weitzel WF, Buffington DA, Westover AJ, MacKay SM, Gutierrez JM, Humes HD: Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals. Blood Purif 2002;20:55-60.
24. Fissell WH, Lou L, Abrishami S, Buffington DA, Humes HD: Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals. J Am Soc Nephrol 2003;14:454-461.
25. Humes HD, Buffington DA, Lou L, Abrishami S, Wang M, Xia J, Fissell WH: Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock. Crit Care Med 2003;31:2421-2428.
26. Humes HD, Weitzel WF, Bartlett RH, Swaniker FC, Paganini EP: Renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure. Blood Purif 2003;21:64-71.
27. Tumlin J, Wali R, Brennan K, Humes HD: Effect of the renal assist device (RAD) on mortality of dialysis-dependent acute renal failure: a randomized, open-labeled, multicenter, phase II trial (abstract). American Society of Nephrology (ASN) 38th Annual Meeting, Philadelphia, 2005.